DESIGN AND EVALUATION OF NOVEL CONTRAST AGENTS FOR MR MOLECULAR IMAGING OF CANCER

DESIGN AND EVALUATION OF NOVEL CONTRAST AGENTS FOR MR MOLECULAR IMAGING OF CANCER

Bibliographic Details
Main Author: Han, Zheng
Language:English
Published: Case Western Reserve University School of Graduate Studies / OhioLINK 2017
Subjects:
Biomedical Engineering
Online Access:http://rave.ohiolink.edu/etdc/view?acc_num=case149139348682434
id ndltd-OhioLink-oai-etd.ohiolink.edu-case149139348682434
record_format oai_dc
spelling ndltd-OhioLink-oai-etd.ohiolink.edu-case1491393486824342021-08-03T07:01:21Z DESIGN AND EVALUATION OF NOVEL CONTRAST AGENTS FOR MR MOLECULAR IMAGING OF CANCER Han, Zheng Biomedical Engineering Magnetic resonance imaging (MRI) is a favorable imaging modality for cancer diagnosis due to its high soft tissue resolution and absence of ionizing radiation. However, most cancers are heterogeneous and existing MRI characteristics are insufficient to precisely delineate tumor aggressiveness for accurate prediction of clinical outcomes. MR molecular imaging aims at mining signatures that are reflections of cellular or subcellular processes in cancer, thereby uncovering hallmarks closely correlated to cancer proliferation, progression and metastasis. In this regard, contrast agents that differentially generate imaging contrast according to tumor aggressiveness is urgently needed. This dissertation is focused on developing novel contrast agents capable of probing the aggressiveness of prostate and breast cancers. Prostate cancer and breast cancer represent the leading causes of morbidity and mortality in men and women, respectively. In addition to the relatively low detection sensitivity, diagnosis of both cancers are suffering from high false-positive rates using current diagnostic techniques. In this work, extradomain-B fibronectin (EDB-FN), an abundant tumor microenvironment molecule exclusively expressed in aggressive tumors, is used as the biomarker. Peptide ligands were developed to specifically target EDB-FN, which were subsequently used to construct a library of gadolinium-based contrast agents. Our results indicate that the contrast agents developed in this work can potentially improve the sensitivity of MRI in detecting malignant cancers, lowering non-specific detection of indolent tumors and reducing gadolinium toxicity. Considering the huge unmet clinical need for accurate risk stratification and reducing overtreatment, this technology hold promise to be incorporated into clinical practice to achieve better diagnostic accuracy and treatment planning. This dissertation is divided into six chapters. Chapter 1 gives an overview of the clinical need for a non-invasive imaging modality for accurate stratification of prostate cancer and breast cancer. EDB-FN as a biomarker for cancer imaging is discussed. Chapter 2 describes the screening of peptide ligands specific for EDB-FN. Chapter 3 and Chapter 4 describe molecular imaging of prostate cancer and breast cancer, respectively, based on EDB-targeting contrast agents. Chapter 5 demonstrates imaging of triple negative breast cancers and metastases with EDB-targeting contrast agents. Chapter 6 is a summary of current work and future directions. 2017-06-02 English text Case Western Reserve University School of Graduate Studies / OhioLINK http://rave.ohiolink.edu/etdc/view?acc_num=case149139348682434 http://rave.ohiolink.edu/etdc/view?acc_num=case149139348682434 unrestricted This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws.
collection NDLTD
language English
sources NDLTD
topic Biomedical Engineering
spellingShingle Biomedical Engineering
Han, Zheng
DESIGN AND EVALUATION OF NOVEL CONTRAST AGENTS FOR MR MOLECULAR IMAGING OF CANCER
author Han, Zheng
author_facet Han, Zheng
author_sort Han, Zheng
title DESIGN AND EVALUATION OF NOVEL CONTRAST AGENTS FOR MR MOLECULAR IMAGING OF CANCER
title_short DESIGN AND EVALUATION OF NOVEL CONTRAST AGENTS FOR MR MOLECULAR IMAGING OF CANCER
title_full DESIGN AND EVALUATION OF NOVEL CONTRAST AGENTS FOR MR MOLECULAR IMAGING OF CANCER
title_fullStr DESIGN AND EVALUATION OF NOVEL CONTRAST AGENTS FOR MR MOLECULAR IMAGING OF CANCER
title_full_unstemmed DESIGN AND EVALUATION OF NOVEL CONTRAST AGENTS FOR MR MOLECULAR IMAGING OF CANCER
title_sort design and evaluation of novel contrast agents for mr molecular imaging of cancer
publisher Case Western Reserve University School of Graduate Studies / OhioLINK
publishDate 2017
url http://rave.ohiolink.edu/etdc/view?acc_num=case149139348682434
work_keys_str_mv AT hanzheng designandevaluationofnovelcontrastagentsformrmolecularimagingofcancer
_version_ 1719451764005011456

Similar Items